Navigation Links
New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
Date:5/15/2008

E450a

metastatic colorectal cancer: First

BEAT

Berry S, et al, Abstract No. 4025,

Poster No. 12.

Avastin The safety of long-term bevacizumab Monday 2 June 2008,

use: Results from the BRiTE 8:00am - 12:00pm, S

observational cohort study (OCS). Hall A1

Purdie D, et al, Abstract No. 4103,

Poster No. 14G

Avastin Safety and effectiveness of Sunday 1 June 2008,

bevacizumab (BV) and chemotherapy 8:00am - 12:00pm,

(CT) in elderly patients (pts) with E450a

metastatic colorectal cancer (mCRC):

Results from the BRiTE observational

cohort study. Kozloff M, et al,

Abstract N0. 4026, Poster No. 13

Full details of key Roche data presentations will be available on Friday 30th May at an invitation-only media event for non-US journalists. All abstracts are available at: http://www.asco.org/ASCO/Meetings .

Editor's note

-- Breast Cancer is one of the most common types of cancer in women, eight

to nine percent of women will develop this cancer during their

lifetime(1). Each year more than one million new cases of breast

cancer are diagnosed(2) with a death rate of over 500,000 people per

year.(3)

-- Avastin doubles the chance of a patient living without their disease

advancing (progression free survival). When used in combination with

taxanes (chemotherapy), Avastin substantially increases the efficacy of

treatment with limited impact on safety. Studies show that continual

direct VEGF inhibition with Avastin maximizes the treatment benefit for

the patient.

-- Herceptin is a humanised antibody sp
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 STUDY OBJECTIVES ... study is to provide an overview of the ... for protein drugs/therapeutics. The key objective is to ... protein drugs as an important tool in the ... present and future strategies within the protein therapeutics ...
(Date:9/30/2014)... DENVER , Sept. 30, 2014  According ... "the world of cancer clinical trials is going ... clinical trials and the work of the current ... these types of ,next generation, clinical trials, which ... tomorrow."  The company has been ...
(Date:9/30/2014)... -- The Chinese wound care market is in the ... incidence of lifestyle diseases, coupled with the increase in ... quality of wound care products provide the impetus for ... health insurance schemes and increased reimbursement rate for wound ... findings of primary and secondary researches, this research service ...
Breaking Medicine Technology:Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2China Wound Care Market 2China Wound Care Market 3
(Date:9/30/2014)... 2014 Integrated Medicine Alliance , ... another new medical specialty practice through a unique partnership ... will be located within the company’s Shrewsbury location and ... Isaac Tawfik of American Heart Center, P.C., a highly ... will offer Integrated Medicine Alliance patients top notch cardiovascular ...
(Date:9/30/2014)... been awarded a three-year $1.7 million grant from ... new imaging technologies and data analysis techniques that ... of neurons in the brain interact to process ... the precise interactions between millions of nerve cells ... alterations in these interactions that may be responsible ...
(Date:9/30/2014)... September 30, 2014 Elevate , the ... perform better in and out of the gym by providing ... caught the attention of Shane Michaels, prompting an investigative review. ... is the reason most people simply just don’t have the ... staying focused at work, getting the motivation to finish a ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... Dr. Karl R.O.S. Johnson, DC, has developed ... care that is dramatically improving the health and lives ... & Nutrition—applies a proprietary, multi-dimensional approach that goes beyond ... of inflammation, neurology of the joint and neurology of ... brain to the spine, to the legs, knees and ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... suggests weight loss may be an early sign of ... before the onset of // definite dementia symptoms and ... in the elderly is common and may be associated ... in people who already have dementia. For the study ...
... researchers have linked breathing cancer-causing compounds during pregnancy // ... They also believe that nearly all childhood cancers can ... noxious substances. ,The study compared a chemical emissions ... died from leukemia and other cancers between 1968 and ...
... the New Year has brought with it a new lease ... For these //patients the uphill struggle doesn’t stop with finding ... , Research has shown that despite all high tech ... a common phenomenon. Transplant surgeon Ignazio Marino, M.D., of Thomas ...
... hormones could be responsible for some of the problems ... measuring levels of five different sex hormones in men ... those found in healthy people. All the MS patients ... brain damage characteristic of the disease. ,Results showed ...
... the use of estrogen replacement therapy with a lower risk ... is known as a good indicator of exposure to estrogen. ... BMD related to the risk of cognitive problems. All of ... of the study. Researchers then measured their BMD at several ...
... a recent study researchers say estrogen may provide protection ... different diets to female mice and followed their progress for ... of specific ingredients.// ,Diet one contained milk protein, and ... of estrogen. The other three diets contained soy protein with ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: